None listed
Conditions
Interventions
Drug : Subjects well receive 80mg/day atorvastatin from two days before radiofrequency catheter ablation, and 40mg/day atorvastatin from one day after procedure to thirty day
Sponsors
Koera University Guro Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age >= 18 2) Subject with atrial fibrillation that is indicated to radiofrequency catheter ablation 3) Radiofrequency catheter ablation must be able to perform 4) Subject who able to take antiplatelet agent (aspirin, clopidogel), anticoagulant agent (warfarin) and antiarrhythmic agent for more than one year 5) Subject who give written consent to this study
Exclusion criteria
Exclusion criteria: 1) Subject with intracardiac thrombus 2) Uncontrolled hypertension 3) Chronic kidney disease (serum creatinine > 2.0 mg/dl) 4) Chronic alcoholics, severe hepatosis (more than three-fold of upper normal range) 5) Subject who is taking prohibited combination drug with atorvastatin (intraconazole, ketoconazole etc.) 6) Chronic obstructive pulmonary disease 7) Significant valvular heart disease 8) History of coagulopathy 9) Chronic heart failure 10) Previous history of radiofrequency catheter ablation 11) Pregnancy 12) Hypersensitibity to contrast 13) Life expectancy under one year due to the other diseases
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular outcome;All cause mortality | — |
Primary
| Measure | Time frame |
|---|---|
| Recurrence rate of tachyarrhythmia | — |
Countries
Korea, Republic of
Contacts
Public ContactJin Oh
Koera University Guro Hospital
Outcome results
None listed